Prognostic role of IL-8 in cancer patients treated with immune checkpoint inhibitors: a system review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been proven to be an effective treatment strategy for a variety of malignant tumors. However, only a subset of patients can benefit from ICIs due to factors such as drug resistance. Therefore, it is crucial to identify biomarkers that can accurate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Dan, Song, Ailin, Yong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446970/
https://www.ncbi.nlm.nih.gov/pubmed/37621675
http://dx.doi.org/10.3389/fonc.2023.1176574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446970/
https://www.ncbi.nlm.nih.gov/pubmed/37621675
http://dx.doi.org/10.3389/fonc.2023.1176574

Ejemplares similares